Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Millions wait for transplants — together, we can bring hope to life

Millions wait for transplants — together, we can bring hope to life

What is Xenotransplantation?

Concept

Transplanting animal-derived organs, tissues, or cells into humans


Types

Solid organs (e.g., kidney, liver, heart), biological tissues, and cellular therapies


Core Value

Addressing the critical global shortage of transplantable human organs

What is Xenotransplantation?
Why Choose Pigs for Xenotransplantation?

Pigs are considered ideal organ donors for xenotransplantation

  • Comparable organ size, and physiological compatibility with humans

  • High genetic tractability and rapid reproductive cycle

  • Lower ethical concerns compared to non-human primates, with manageable risk of zoonotic disease transmission

  • Well-established husbandry practices ensure a stable and reliable medical-grade organ supply

Why Choose Pigs for Xenotransplantation?
About ClonOrgan
China's Leading Xenotransplantation Enterprise

ClonOrgan is long-term dedicated to the in-depth R&D of xenotransplantation donor pigs;

Cultivating China's largest population of gene-edited, low-immunogenicity donor pigs;

Developing therapeutic technologies using transplantable pig organs and tissues, including kidneys, livers, hearts, skin, red blood cells.

  • Professor Dengke Pan

    Professor Dengke Pan

  • Professor Shaoping Deng

    Professor Shaoping Deng

News
Company News
Media Coverage
Science Outreach
Science Literature
  • TTS 2026 | 异种移植登上全球主舞台,中国团队成果备受瞩目

    2026/09/29 Company News
    NEWS2026年9月20-23日,恰逢国际移植学会(TTS)创立60周年之际,第31届国际移植学会大会(TTS 2026)于澳大利亚悉尼国际会议中心举办,汇聚全球76个国家和地区2300余名移植领域专家学者和器官移植工作者,围绕同种与异种移植的免疫机制、外科技术、器官保存、临床转化等议题开展深度研讨。本届大会,异种移植首次登上主旨报告舞台,成为备受关注的热点领域。大会上,中国团队的成果报告引大会...
  • 中科奥格基因编辑猪助力全球首例异种原位全肝移植研究登上顶刊

    2026/09/17 Company News
    企业新闻2026年9月16日,中科奥格与西京医院窦科峰院士团队合作的全球首例基因编辑猪-脑死亡人受试者异种原位全肝移植研究论文“Orthotopic Liver Xenotransplantation from Gene-Modified Pig to Decedent Human ”正式在Nature Biomedical Engineering期刊发表,中科奥格董事长潘登科研究员为论...